By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sanofi Pasteur MSD 

Mallards Reach, Bridge Avenue

Maidenhead    SL6 1QP  United Kingdom
Phone: 44-1628-785-291 Fax: 44-1628-671-722




Company News
Sanofi Pasteur MSD: The Four-Type HPV Vaccine Gardasil(R) Demonstrates Real Life Benefits 5/8/2009 1:41:24 PM
Sanofi Pasteur MSD Release: New Results Confirm That Young Women Up To The Age Of 26 Years Can Benefit From Vaccination With Gardasil(R) 2/17/2009 2:39:11 PM
Sanofi Pasteur MSD Release: Gardasil(R) Vaccine Honoured with International Galien Prize for Pharmaceutical Research 10/31/2008 12:33:08 PM
Sanofi Pasteur MSD Announces Cross-Protective Effect and Prevention of Precancerous Vaginal Lesions Added to Product Information of Gardasil(R) 9/12/2008 12:00:21 PM
Sanofi Pasteur MSD Release: Sustained High Efficacy of Gardasil(R) Against Early Cervical Lesions, Precancerous Vulvar and Vaginal Lesions, and Genital Warts in Longest Follow-up of Large Phase III Studies 3/12/2008 4:19:27 PM
Sanofi Pasteur MSD Welcomes Sweden's Decision to Recommend and Fund Human Papillomavirus Vaccination for School Girls 2/28/2008 4:29:15 PM
Sanofi Pasteur MSD Applies for European Approval of the First Seasonal Influenza Vaccine Delivered by Intradermal Microinjection 2/13/2008 7:55:02 AM
Sanofi Pasteur MSD Launches New Website 5/21/2007 2:32:03 PM
Federal Advisers Endorse 5-In-1 Vaccine 1/26/2007 2:13:56 AM
Sanofi Pasteur MSD's Gardasil Receives Positive Opinion From European Medicine Agency 7/28/2006 4:52:09 PM